0 XP 0   0   0  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Revolution Medicines Inc - Trending symbols

Latest News of Revolution Medicines Inc

DateTitleRead
2025-09-11
20:55
Revolution Medicines (RVMD) Announces Promising Phase 1 Daraxonrasib Clinical Trial ResultsRead
2025-09-10
23:16
Revolution Medicines rises on daraxonrasib data that supports phase 3 programRead
2025-09-10
22:02
Revolution Medicines Shares New Clinical Results Supporting Initiation of RASolute 303, a Global Phase 3 Registrational Trial of Daraxonrasib in First Line Metastatic Pancreatic Ductal AdenocarcinomaRead
2025-08-19
20:46
Summit draws Neutral view on risk/reward setup as Piper initiates biotech cancer namesRead
2025-08-18
19:36
Revolution Medicines' SWOT analysis: promising cancer drug stock faces pivotal yearRead

Notifications

TypeNotificationDate
RSI OverboughtOverbought RSI (Relative Strength Index)2025-09-12



Trends

 2020-12-312021-12-312022-12-312023-12-312024-12-31
Income Tax Expense -371-6,949-7,3206,900-420-3,104-3,5244,277753
Accumulated Other Comprehensive Income -1,7801,224-556-695-1,251380-8711,415544
Depreciation and Amortization 5,077-2,5442,533-7601,7733722,145-8,596-6,451

Comments

How you think about this?

Leave a comment

Stay informed about Revolution Medicines Inc.

Receive notifications about Revolution Medicines Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.